Search

The article discusses new research findings on meningeal neoplasms, focusing on a case study of a 60-year-old male with recurrent atypical meningioma in the right parietal lobe. The study utilized somatostatin receptor positron emission tomography/computed tomography (SR-PET/CT) to confirm the recurrence of the meningioma, revealing a unique "rosary sign" pattern. This novel imaging technique improved diagnostic accuracy and identified additional lesions not visible on MRI, leading to the proposal of peptide receptor radionuclide therapy (PRRT) as a potential treatment option for the patient. [Extracted from the article]

Researchers at Case Western Reserve University conducted a study on the outcomes of adjuvant radiation treatment following subtotal resection of World Health Organization Grade II meningiomas. The study included 39 patients who received either intensity-modulated radiation therapy (IMRT) or stereotactic radiosurgery (SRS) between 1996 and 2020. The results showed that there was no significant difference in progression-free survival or radiation necrosis between patients treated with adjuvant IMRT versus SRS. This research provides valuable insights for counseling patients with WHO Grade II meningiomas. [Extracted from the article]

A recent case report from the University of Medicine and Pharmacy in Bucharest, Romania, details the management of a rare giant convexity en plaque anaplastic meningioma in a 76-year-old male patient with Gerstmann syndrome. The patient underwent near-total tumor resection, resulting in significant improvement in neurological deficits, particularly in expressive language and cognitive function, suggesting potential reversibility of Gerstmann syndrome. The study highlights the challenges and outcomes of surgical management for such complex cases, emphasizing the potential for neurological recovery in patients with tumor-induced Gerstmann syndrome. [Extracted from the article]

A recent study from Yale University School of Medicine focused on meningeal neoplasms, specifically in the context of meningioma surgery. The research highlighted the importance of preoperative imaging with computed tomography angiography (CTA) in understanding the relationship of tumors with neurovascular structures. The study emphasized the limitations of CTA in accurately representing hypoplastic arterial segments, recommending the use of microvascular Doppler during surgery to avoid potential pitfalls. This research provides valuable insights for surgical strategies in treating meningeal neoplasms. [Extracted from the article]

A recent report highlights the challenges and techniques involved in removing ossified spinal meningiomas, a rare form of spinal tumor. Researchers from the Department of Neurological Sciences in Udine, Italy, discuss the clinical findings, surgical strategies, and histological findings of a patient with a thoracic ossified meningioma. The study emphasizes the potential of using a piezosurgery device to reduce operating time and enhance surgical safety in removing these calcified masses. For more information, readers can access the full article in Neurosurgery Practice. [Extracted from the article]

A study conducted at the City of Hope National Medical Center in Duarte, California, focused on treatment options for WHO grade 2 meningiomas, which account for approximately 20% of all meningiomas. The research highlighted the challenges in defining optimal treatment modalities due to the lack of randomized data and presented treatment recommendations from experts in central nervous system radiation oncology and neurosurgery. The study concluded that both conventional and stereotactic radiation therapy are viable options for WHO grade 2 meningiomas, with more studies needed to determine the optimal approach. [Extracted from the article]

Researchers at University Hospital Heidelberg conducted a study on meningeal neoplasms, specifically meningiomas, which are the most common primary intracranial tumors in adults. The study focused on sex-specific differences in mutations, methylation classes, copy number variations, and histology of meningiomas, revealing that females with malignant tumors often exhibit a loss of one X chromosome, leading to a worse progression-free survival. The findings suggest that leveraging gonosomal copy number status can enhance diagnostic accuracy in meningioma cases. [Extracted from the article]

Researchers from Udayana University in Bali, Indonesia, have published a rare case report on an ectopic meningothelial meningioma of the soft palate, a type of meningeal neoplasm. The study documents the case of a 52-year-old woman with a mass in her mouth, which was diagnosed as an ectopic meningioma. The research highlights the challenges in diagnosing and treating tumors in uncommon sites like the palate, emphasizing the importance of factors such as histology and tumor grade in determining prognosis. [Extracted from the article]

A recent study conducted by researchers at Kumamoto University focused on the differentiation between hemorrhage and iodine extravasation in meningiomas after preoperative embolization. The study utilized dual-energy computed tomography (DECT) to assess the efficacy of this method. Results showed that DECT with virtual noncontrast (VNC) imaging and iodine maps (IM) was useful in distinguishing between hemorrhage and iodine extravasation in meningiomas with preoperative embolization. The study concluded that the addition of VNC imaging and IM to conventional computed tomography (CCT) improved differential confidence in diagnosing these conditions. [Extracted from the article]

A recent study conducted by the University of Cincinnati focused on the use of immune checkpoint inhibitors for patients with recurrent grade II/III meningiomas. The research highlighted that these inhibitors show promise as a potential therapy for these types of tumors, particularly for those with mismatch repair deficiency or high tumor mutational burden. The study emphasized the need for further investigations with prospective patient enrollments and standardized assessment of radiographic response to advance the understanding of this treatment approach. [Extracted from the article]

A recent study conducted at New York University (NYU) focused on the outcomes of radiosurgery for WHO Grade 2 meningiomas, specifically examining the role of the Ki-67 index in guiding tumor margin dose. The research involved a cohort of 99 patients with WHO Grade 2 meningiomas who underwent stereotactic radiosurgery (SRS) between 2011 and 2023. The study found that a personalized SRS approach, guided by predictive biomarkers such as Ki-67 index, can be valuable in managing WHO Grade 2 meningiomas. The research highlights the importance of a multimodality approach in treating these complex tumors. [Extracted from the article]

A recent study from the University of Lorraine in Nancy, France, focused on personalized medicine in the treatment of refractory meningiomas using 177 Lu-labeled somatostatin receptor-targeted radiopeptide therapy. The research highlighted the importance of tumor dosimetry in individualized treatment plans and emphasized the need for standardized methodologies to optimize patient care. The findings suggest that dosimetry calculations play a crucial role in improving outcomes for patients with meningiomas. [Extracted from the article]

A recent study conducted at University Hospital Munster in Germany focused on the predictability of postoperative meningioma resection status based on clinical features. The research analyzed 23 clinical features to distinguish between gross total resections (GTR) and subtotal resections (STR) of meningiomas. The study developed a model with high discriminatory power, achieving a mean accuracy of 0.866, which can aid in surgical planning and postoperative treatment decisions. This research provides valuable insights for clinicians and researchers in the field of central nervous system neoplasms. [Extracted from the article]

A recent study conducted by Yonsei University in Seoul, South Korea, focused on identifying serum biomarkers to predict the prognosis of atypical meningiomas. The research, which included 523 patients from 5 Asian institutions, found that certain serum markers were associated with higher or lower progression/recurrence rates in patients with atypical meningiomas. The study concluded that further research is needed to validate the clinical significance and biological background of these findings. [Extracted from the article]

Researchers at Tongji University School of Medicine have identified SNAP25 as a potential prognostic marker in meningioma, the most common intracranial tumors. Through gene expression analysis and various molecular studies, they found that SNAP25 was downregulated in meningiomas and could serve as a favorable prognostic factor. This research sheds light on the importance of exploring molecular targets for accurate diagnosis and prognosis in meningeal neoplasms. [Extracted from the article]

The article discusses the use of Convolutional Neural Networks (CNNs) in accurately classifying and grading preoperative meningioma tumors using multimodal CT and MRI images. The study fine-tuned a pre-trained CNN model on various brain tumor types and meningioma subtypes, achieving over 98% accuracy with high recall and precision scores. The CNN models showed potential as alternatives to invasive biopsies and human evaluation, offering a cost-effective and robust method for diagnosing complex meningioma cases. The research has not yet undergone peer review and provides promising avenues for other tumor types and diagnostic modalities. [Extracted from the article]

A recent study conducted by the Department of Radiology focused on predicting postoperative progressive cerebral edema and hemorrhage after meningioma resection. The researchers developed a multiparametric MRI radiomics model that integrated clinical and radiomics features to accurately predict these complications. The study highlighted the importance of peritumoral brain edema radiomics features in understanding the mechanisms of postoperative complications. This research provides valuable insights into improving outcomes for patients undergoing meningioma resection. [Extracted from the article]

A recent study conducted at the Roswell Park Comprehensive Cancer Center focused on primary intraosseous meningiomas, which are rare extradural tumors that are typically slow-growing and asymptomatic until they cause symptoms. The study reported a case of a 67-year-old female who presented with stroke-like symptoms due to a calvarial primary intraosseous meningioma. The research emphasized the importance of histopathological examination for accurate diagnosis and treatment planning, which may involve skull resection, radiation, or both. For more information, the full article can be accessed through the Journal of Surgical Case Reports. [Extracted from the article]

Researchers at Mount Sinai Health System conducted a study on meningeal neoplasms, aiming to develop machine learning models for predicting meningioma grades using MRI data. The study utilized a dataset with 698 patients and found that the CatBoost model showed the best performance in differentiating low-grade from high-grade meningiomas. The research highlights the potential for non-invasive pre-operative grading of meningiomas using radiomics-driven machine learning, but further validation on larger datasets is needed for robustness and generalizability. [Extracted from the article]

Researchers from the Mexican Social Security Institute conducted a study on the resection of petrotentorial and petroclival meningiomas using a retrosigmoid suprameatal approach. This approach was found to be effective in achieving gross total resection of the tumors while maintaining neurological integrity in two patients. The research emphasizes the importance of choosing the optimal surgical approach based on tumor characteristics and surgeon experience. The study was published in Operative Neurosurgery and can be accessed for further information. [Extracted from the article]

A study conducted at Emory University examined the impact of social determinants on the receipt of adjuvant radiation following atypical meningioma surgery. The research found that patients over 65, women, those residing in the Southern USA, those living further from their facilities, and uninsured patients were less likely to receive radiation compared to their counterparts. Disparities exist in the administration of adjuvant radiation for atypical meningioma patients, highlighting the need for further investigation and intervention to address these gaps in care. [Extracted from the article]

A recent study conducted by Harvard Medical School focused on cerebellopontine angle (CPA) meningiomas, which are challenging due to their proximity to neurovascular structures. The study examined the presentation, management, and outcomes of 95 patients with CPA meningiomas, finding that gross total resection (GTR) is crucial for symptom control and reducing progression/recurrence rates. The research highlighted the importance of drilling the internal auditory canal (IAC) as a predictor of GTR in tumors with intracanalicular invasion. This study provides valuable insights for clinicians and researchers in the field of neurosurgery. [Extracted from the article]

Research from Washington University School of Medicine delves into the complexities of multiply recurrent meningiomas, identifying risk factors, underlying biology, and insights into their evolution. The study highlights the association of male sex, subtotal resection, and histopathological sheeting with multiply recurrent meningiomas. Multiomic analysis reveals greater copy number losses and increased DNA methylation in these tumors, offering potential implications for future biomarkers and therapeutic strategies. This investigation sheds light on the challenging nature of multiply recurrent meningiomas and their clinical implications. [Extracted from the article]

A recent study conducted at the University of California in Orange provides new insights into meningeal neoplasms, specifically focusing on staged resection of difficult-to-treat intracranial meningiomas. The research highlights the benefits of multistaged surgeries for complex, multicompartmental lesions, emphasizing maximal safe resection while minimizing adverse effects. The study found that staged resections are generally well-tolerated, but more comparative evidence is needed to definitively determine its advantages over unstaged approaches. Collaborative efforts among skull base surgeons are recommended to establish evidence-based guidelines for the use of staged approaches in meningioma resection. [Extracted from the article]

A study conducted at Mansoura University Faculty of Medicine in Egypt focused on the surgical management and functional outcomes of giant olfactory groove meningiomas (OGMs) larger than 6 cm. The research evaluated different surgical approaches and outcomes in 71 patients, with the bifrontal approach being the most commonly used and resulting in better resection of OGMs, although it was associated with more complications. The study also observed significant postoperative improvements in functional outcomes, such as visual acuity and cognitive function. [Extracted from the article]

A recent study conducted by the University of California San Francisco (UCSF) focused on meningeal neoplasms, specifically low-grade meningiomas that can recur after surgery. The research utilized targeted gene expression profiling to improve risk stratification of meningiomas, identifying clinical low-risk cases likely to recur post-surgery. The study, which included 723 patients, found that combining gene expression biomarkers with the extent of resection could predict unfavorable outcomes in a subset of clinical low-risk meningiomas. This research sheds light on the potential of gene expression profiling in identifying meningiomas at risk of recurrence. [Extracted from the article]

A recent study conducted at the Prince of Wales Private Hospital in Randwick, Australia, examined the relevance of the Simpson grading scale in modern neurosurgery for the resection of Grade I meningiomas. The research suggests that advancements in neuroimaging, microsurgical techniques, and radiotherapeutic strategies have changed the interpretation of recurrence rates and the clinical significance of the Simpson Scale. The study emphasizes the importance of gross tumor resection, adjuvant radiation therapy, and updated WHO classifications in meningioma surgery, highlighting the need for balanced risk-benefit decisions throughout the operation. [Extracted from the article]

A recent report from King Abdullah Medical City discusses a rare case of angiomatous meningioma with intracerebral hemorrhage in a 65-year-old female. The patient presented with focal left upper limb epileptic attacks, and imaging revealed a right occipital meningioma causing the hemorrhage. Surgical resection confirmed the diagnosis of angiomatous meningioma. This research provides valuable insights into the diagnosis and treatment of rare meningioma subtypes. [Extracted from the article]

A study conducted at the University of Texas MD Anderson Cancer Center in Houston, Texas, focused on evaluating MTAP and p16 immunohistochemistry (IHC) markers as surrogates for CDKN2A/B loss in meningiomas. The research aimed to provide a faster and more cost-effective method for assessing CDKN2A/B status in these tumors. The study found that MTAP IHC showed promise as a surrogate marker for evaluating CDKN2A status in meningiomas, offering potential benefits for diagnostic and screening purposes. [Extracted from the article]

Researchers from the University of Manitoba reported on a case of a woman who developed multiple intracranial meningiomas after long-term therapy with synthetic progesterone. Upon discontinuation of the medication, the meningiomas showed near complete regression, as confirmed by a CT scan and autopsy findings. This case study provides valuable insight into the potential effects of synthetic progesterone on meningiomas, with histopathologic characterization being a key aspect of the research. The study highlights the importance of monitoring and evaluating the impact of long-term medication use on central nervous system neoplasms. [Extracted from the article]

Researchers from Nihon University School of Medicine published a case report on intraoperative neuromonitoring of visual evoked potentials in a pregnant patient with meningioma. The study highlighted the challenges of anesthesia management in pregnant women undergoing enucleation surgery for parasellar meningioma. The use of remimazolam for anesthesia allowed safe brain surgery with intraoperative monitoring, resulting in restored visual acuity postoperatively without adverse events to the fetus. Further research is needed to determine the effects of remimazolam on the fetus and establish safe dosage and exposure duration. [Extracted from the article]

A recent study published in the Journal of Personalized Medicine explores the potential use of virtual reality with a supraorbital keyhole craniotomy for anterior skull base meningiomas. The research, conducted at Larkin Community Hospital in Miami, Florida, involved two cases where patients underwent minimally invasive tumor resection using augmented reality and virtual reality for preoperative planning. The study emphasizes the importance of individualized patient selection and surgical expertise when considering this approach, highlighting the role of VR/AR technologies in optimizing outcomes and expanding the implementation of the procedure. [Extracted from the article]

Researchers at Kermanshah University of Medical Sciences in Iran published a study on a rare and aggressive type of meningioma known as rhomboid meningioma (RM). The study focused on a 67-year-old man from Kermanshah City who underwent surgical intervention for the excision of a mass on his skull, which was diagnosed as RM (WHO grade III). The research highlighted the importance of early diagnosis and treatment for meningiomas, especially in invasive cases, to prevent complications and improve prognosis. The study was published in the Iranian Journal of Neurosurgery and can be accessed for more information. [Extracted from the article]

A recent study conducted by Columbia University focused on Salvage Stereotactic Radiosurgery for Recurrent WHO Grade 2 and 3 Meningiomas. The study aimed to address the lack of guidelines for managing recurrent grade 2 and 3 meningiomas, with promising results showing favorable local control rates and toxicity profiles. The research, which involved a multicenter retrospective cohort study, highlighted the importance of further prospective validation in this area of treatment. The study was supported by various organizations and has been peer-reviewed for accuracy and validity. [Extracted from the article]